Iambic Therapeutics launches AI drug discovery model "Enchant" with 0.74 accuracy, potentially cutting drug development costs in half.

Iambic Therapeutics, supported by Nvidia, has launched "Enchant," an AI drug discovery model that predicts a drug's effectiveness during early development stages with 0.74 accuracy, surpassing previous models' 0.58 score. This innovation could potentially reduce drug development costs by half. The advancement aligns with the growing integration of AI and other technologies in the pharmaceutical sector, which is projected to expand significantly by 2031.

October 29, 2024
10 Articles

Further Reading